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Abstract 
Background: Recent genome wide analysis studies have identified a strong association between single nucleotide 
variations within the human ATP2B4 gene and susceptibility to severe malaria. The ATP2B4 gene encodes the plasma 
membrane calcium ATPase 4 (PMCA4), which is responsible for controlling the physiological level of intracellular 
calcium in many cell types, including red blood cells (RBCs). It is, therefore, postulated that genetic differences in the 
activity or expression level of PMCA4 alters intracellular  Ca2+ levels and affects RBC hydration, modulating the inva‑
sion and growth of the Plasmodium parasite within its target host cell.
Methods: In this study the course of three different Plasmodium spp. infections were examined in mice with sys‑
temic knockout of Pmca4 expression.
Results: Ablation of PMCA4 reduced the size of RBCs and their haemoglobin content but did not affect RBC matura‑
tion and reticulocyte count. Surprisingly, knockout of PMCA4 did not significantly alter peripheral parasite burdens 
or the dynamics of blood stage Plasmodium chabaudi infection or reticulocyte‑restricted Plasmodium yoelii infection. 
Interestingly, although ablation of PMCA4 did not affect peripheral parasite levels during Plasmodium berghei infec‑
tion, it did promote slight protection against experimental cerebral malaria, associated with a minor reduction in 
antigen‑experienced T cell accumulation in the brain.
Conclusions: The finding suggests that PMCA4 may play a minor role in the development of severe malarial compli‑
cations, but that this appears independent of direct effects on parasite invasion, growth or survival within RBCs.
© The Author(s) 2021. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, 
adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and 
the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material 
in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material 
is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds 
the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://crea‑
tivecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdo‑
main/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
Open Access
Malaria Journal
*Correspondence:  kevin.couper@manchester.ac.uk; delvac.
oceandy@manchester.ac.uk
†Kevin N. Couper and Delvac Oceandy contributed equally as senior 
authors
1 The Lydia Becker Institute of Immunology and Inflammation, 
Faculty of Biology, Medicine and Health, University of Manchester, 
Manchester M13 9PT, UK
2 Division of Cardiovascular Sciences, Faculty of Biology, Medicine 
and Health, Manchester Academic Health Science Centre, The University 
of Manchester, Manchester M13 9PT, UK
Full list of author information is available at the end of the article
Page 2 of 16Villegas‑Mendez et al. Malar J          (2021) 20:297 
Background
Malaria is a major public health problem in developing 
countries, primarily in sub-Saharan Africa and Asia [1]. 
There were 229 million clinical cases of malaria resulting 
in approximately 409,000 deaths reported in 2019, mak-
ing malaria one of the most prevalent and deadly infec-
tious diseases in the world [1]. Despite significant efforts 
to reduce the incidence of malaria in the past decade, pro-
gress in controlling and eliminating malaria has stalled in 
the last 2–3 years, with the number of infections begin-
ning to rise in a number of countries [1, 2]. Moreover, 
there is increasing evidence that Plasmodium falciparum 
parasites, the causative agent of malaria, are developing 
resistance to a number of front-line anti-malarial drugs 
(such as artemisinin), which has the potential to severely 
impact malaria control in the future [3, 4]. Consequently, 
there is still an urgent need to develop new treatments 
for malaria.
Understanding the critical host pathways that control 
the susceptibility and resistance of individuals to malaria 
in endemic countries may afford novel strategies to treat 
severe malaria. A recent human genome wide associa-
tion study (GWAS) in Kenya identified single nucleotide 
polymorphisms (SNPs) in the human plasma membrane 
calcium ATPase 4 (PMCA4) gene (also called ATP2B4) to 
have a very strong association with resistance and sever-
ity of malaria infection [5]. This study confirmed results 
in two earlier GWAS (one in Ghana and one multi-site 
across Africa, Asia and Oceania) identifying ATP2B4 as 
a significant resistance loci for severe malaria [6, 7]. The 
reproducibility in identification of ATP2B4 across differ-
ent populations and studies suggests a major role for the 
gene product of ATP2B4 in modulating the severity of 
Plasmodium infection.
PMCAs are ATP-driven and calmodulin-dependent 
calcium pumps that eject calcium from the cell cytoplasm 
to the extra-cellular compartment [8]. There are four 
PMCA isoforms that have been identified (PMCA1-4). 
It is believed that PMCA1 and PMCA4 are ubiquitously 
expressed whereas PMCA2 and PMCA3 expressions are 
confined to specific tissues [9]. Importantly, PMCA4 
expression can be detected in red blood cells (RBC), the 
target cell of Plasmodium parasites during blood-stage 
malaria. In RBC, PMCA is the only active calcium extru-
sion pump required to maintain intracellular calcium in 
the 20–50  nM range [10]. Thus, inhibition of PMCA4 
activity significantly elevated intracellular calcium in 
RBCs [10, 11]. Notably, the growth defect of Plasmodium 
parasites in cold stored (4 °C) RBCs has been associated 
with inhibition of PMCA channel activity and increased 
intracellular  Ca2+ concentrations [12]. The increase in 
intracellular  Ca2+ concentrations can lead to RBC dehy-
dration [13], and there is evidence that P. falciparum 
parasites are unable to invade and grow as efficiently in 
dehydrated RBCs [14]. Targeting and manipulating the 
activity of PMCA4 may, therefore, be a novel strategy for 
treatment of malaria.
In this study to directly assess the role of PMCA4 
in modulating the course of blood stage malaria, mice 
with a systemic genetic knockout of the Pmca4 gene 
 (PMCA4−/− mice) were infected with different species of 
murine Plasmodium parasites. Surprisingly, whilst abro-
gation of PMCA4 influences the morphology and biology 
of RBCs, it did not substantially affect peripheral parasite 
levels during Plasmodium yoelii, Plasmodium chabaudi 
or Plasmodium berghei infections. Inhibition of PMCA4 
did, however, slightly increase the resistance of mice to 
experimental cerebral malaria (ECM). The results suggest 
that PMCA4 may have an effect on the development of 




All animal work was approved following local ethical 
review by the University of Manchester (UoM) Animal 
Procedures and Ethics Committees and was performed 
in strict accordance with the U.K Home Office Animals 
(Scientific Procedures) Act 1986 (approved H.O Project 
Licence P8829D3B4).
Mice and infections
PMCA4 global knock out  (PMCA4−/−) mice and wild 
type (WT) littermates were used in this study. Genera-
tion of  PMCA4−/− mice was described in our previous 
publication [15]. Uninfected global  PMCA4−/− mice are 
generally normal, as defined by whole body phenotype 
analysis [16]. Mice were bred at the Biological Service 
Facility (BSF), University of Manchester. All mice were 
maintained in specific-pathogen free conditions in indi-
vidually ventilated cages. The Plasmodium chabaudi 
used was the non-lethal AS strain obtained from Dr 
K.N. Brown (National Institute for Medical Research 
(NIMR), London) [17]. The Plasmodium yoelii NL strain 
was obtained from Dr Brian De Souza (UCL, London) 
[18], whereas the Plasmodium berghei ANKA used was 
the clone cl15cy1 as described in [19]. Depending upon 
the experiment, cryopreserved P. chabaudi AS, P. yoelii 
Keywords: PMCA4, Malaria, Knockout mice, Plasmodium, Cerebral malaria, Red blood cell
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NL or P. berghei ANKA parasites were passaged once in 
C57BL/6 mice before experimental mice were infected 
via intravenous (i.v.) injection of  104 parasitized red 
blood cells (pRBC) of one of the Plasmodium species. 
The course of infection was monitored by assessing 
peripheral parasitaemia via microscopic examination of 
Giemsa-stained thin blood smears, by calculating mouse 
weight on specified days of infection (compared to start-
ing weight at initiation of experiment), and by quantify-
ing erythrocyte numbers in peripheral blood (RBC /ml) 
by microscopy using a C-Chip disposable haemocytom-
eter (Cambridge Bioscience). ECM was graded during 
P. berghei ANKA infection as previously described [20]: 
1 = no signs; 2 = ruffled fur/and or abnormal posture; 
3 = lethargy; 4 = reduced responsiveness to stimulation 
and/or ataxia and/or respiratory distress/hyperventila-
tion; 5 = prostration and/or paralysis and/or convulsions. 
Stages 2 and 3 were classified as prodromal ECM and 
stages 4–5 were classified as ECM. Plasmodium berghei 
infected mice were euthanized when they reached stage 
4/5. To examine the permeability of the blood brain 
barrier (an important event during ECM), mice were 
injected i.v. with 200 ml of 1% Evans blue (Sigma Aldrich, 
UK) on day 6 of P. berghei infection. After one hour, mice 
were culled and intra-cardiac whole-body perfusion with 
15 ml of PBS was performed, following which brains were 
removed.
Automated blood analysis
For peripheral blood analysis, mice were anesthetized 
using 2.5% isoflurane and blood was collected from the 
jugular vein. Blood samples were analysed within 6  h 
after collection using an automated blood analyser (Sys-
mex XT-2000iV) at room temperature. Blood analysis 
was carried out in 2 batches using a mouse profile.
Western blot
For western blot analysis of erythrocyte PMCA expres-
sion, blood was collected from the jugular vein of 
 PMCA4−/− and WT mice under anaesthesia with 2.5% 
isoflurane, and heparinized. Blood was centrifuged 
at 1800g for 5  min and the plasma and buffy coat were 
discarded. Erythrocytes were then washed 4 times in 
twice their volume of 0.9% saline, with centrifugation for 
5  min at 1200g. Packed erythrocytes were then lysed in 
10 × their volume of RIPA buffer (containing 1% IGEPAL 
CA-630, 0.5% sodium deoxycholate, 0.1% SDS, 0.5  mM 
phenylmethylsulphonyl fluoride, 500  ng/ml Leupeptin, 
1 mg/ml Aprotinin and 2.5 mg/ml Pepstatin A), and 10 µl 
of the resultant lysate was separated by SDS-PAGE and 
transferred to PVDF membranes (Millipore) using stand-
ard protocols.
Membranes were blocked in 3% BSA (for PMCA4 
detection) or 3% non-fat milk (for PMCA1 detection) for 
1 h at room temperature, before refrigerated incubation 
overnight with primary antibodies against PMCA4 (clone 
JA9-Abcam) or PMCA1 (clone F-10-Santa Cruz). Pro-
teins were visualized the following day using enhanced 
chemiluminescence (GE Healthcare), after incubation 
with HRP-linked anti-mouse or anti-rabbit secondary 
antibody (Cell Signalling) on a ChemiDoc XRS Imaging 
System (Biorad). Membranes were then incubated with 
β-actin or GAPDH antibody (abcam) as loading control.
Image stream
Heparinized blood obtained from the tail vein was 
surface stained for 25  min at 4 ΟC with anti-Ter119 
(Ter119—BioLegend), anti-CD44 (IM7—Thermofisher) 
and anti-CD71 (R17217—Thermofisher), before being 
washed and resuspended in PBS containing DAPI. Cells 
were analysed with an ImageStream X Mk II (Amnis) and 
data was analysed with IDEAS (Amnis).
Analysis of RBCs morphology following Plasmodium 
infection
Images of Giemsa-stained thin blood smears from WT 
and  PMCA4−/− mice on days 7 and 9 of P. chabaudi 
and P. yoelii infection were uploaded to Image Pro Pre-
mier image analysis software. Automated classification of 
RBCs was performed with a lower size threshold of 3000 
pixels (to exclude small cell fragments and circulating 
material) and a roundness threshold of < 1.2 (to exclude 
overlapping cell populations). A total of 38 fields of view 
from 3 mice per group per time point was analysed.
Flow cytometry
Spleens were removed from infected and uninfected 
 PMCA4−/− and WT control mice and homogenized 
through a 70 µm cell sieve to create single cell suspensions 
(BD Biosciences). RBCs were lysed in the samples by addi-
tion of RBC lysing buffer (BD Biosciences), following which 
cells were washed and resuspended in HBSS containing 2% 
FCS (FACS buffer). Brains were isolated from mice after 
intra-cardial perfusion with PBS, chopped into small pieces 
using scissors, and passed through a 10 ml syringe, before 
being incubated on a tube roller at room temperature in 
FACS buffer with Collagenase (final concentration 1  mg/
ml) (Sigma) for 45 min. The resultant brain cell suspensions 
were filtered through a 70 µm cell sieve, washed in FACS 
buffer, and layered on a 30% Percoll gradient and centri-
fuged at 2000g for 10 min. The supernatant was discarded 
and the cell pellet collected. RBCs were lysed in the sam-
ples by addition of RBC lysing buffer (BD Biosciences) and 
cells were washed and resuspended in FACS buffer. Abso-
lute cell numbers were determined by microscopy using 
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a haemocytometer and live/dead differentiation was per-
formed using the trypan blue exclusion cell viability assay 
(Sigma).
Spleen and brain samples were surface stained for 20 min 
with anti-mouse CD4 (GK1.5—Thermofisher), anti-
mouse CD8a (53–6.7—Thermofisher), anti-mouse CD11a 
(M17/4—Thermofisher), anti-mouse CD11b (M1/70—
BioLegend), anti-mouse CD31 (390—BioLegend), anti-
mouse CD45 (30-F11—Thermofisher), anti-mouse CD49d 
(R1-2—BioLegend), anti-mouse ICAM-1 (YN1/1.7.4—
BioLegend), anti-mouse Ly6C (HK1.4—BioLegend) and 
anti-mouse Ly6G (1A8—BioLegend). Intracellular staining 
for granzyme B (GB11—BioLegend) was performed for 
45 min, after treatment with Foxp3 fixation/permeabiliza-
tion buffer (Thermofisher). Dead cells were identified and 
exluded from analysis using LIVE/DEAD® Fixable Blue 
Dead Cell Stain Kit (Life Technologies). Fluoresce minus 
one controls were used to set gates. Cells were analysed 
with a BD LSR II (Becton Dickinson) using BD FACS-
Diva software (Becton Dickinson). Data was analysed with 
FlowJo (Tree Star Inc.).
Statistical analyses
Data was tested for normality using the Shapiro–Wilk 
test. Unpaired two tailed t test (for parametric data) or the 
Mann–Whitney U test (for non-parametric data) was used 
for comparison between two groups. One-way ANOVA, 
with Tukey post hoc analysis, or the Kruskal–Wallis test, 
with Dunn post hoc analysis, were used for comparisons 
between three or more groups, for parametric and non-
parametric data, respectively. Survival data was analysed 
using the Mantel-Cox test. Results were considered as sig-
nificantly different when p < 0.05.
Results
Effects of PMCA4 ablation on RBC size and maturation 
state
To investigate how PMCA4 controls murine RBC biol-
ogy, RBCs from mice with a global knockout of the Pmca4 
gene (generated via deletion of exon 2 of mouse Pmca4 
gene, which contains the start codon) were analysed [15]. 
Western blot analysis of whole blood lysates confirmed 
the complete ablation of PMCA4 expression in blood 
of  PMCA4−/− mice, compared with WT control mice 
(Fig. 1A). Importantly, PMCA1 was expressed at a low level 
in whole blood of WT mice, indicating that PMCA4 was 
the dominant PMCA on circulating blood cells (Fig.  1B). 
The level of PMCA1 was, however, slightly increased on 
whole blood lysates from  PMCA4−/− mice, potentially as a 
compensatory response (Fig. 1B).
Analysis using an automatic blood analyser system 
indicated that the RBCs of  PMCA4−/− mice were slightly 
smaller in size than RBCs of control mice as shown by 
the mean corpuscular volume (MCV) values. Moreover, 
RBCs of  PMCA4−/− mice also had lower mean corpus-
cular haemoglobin (MCH) values than RBCs from con-
trol mice, suggesting that the cells in the  PMCA4−/− mice 
had less haemoglobin per RBC. Other RBC parameters 
such as RBC total count, haemoglobin level and haema-
tocrit were not altered in  PMCA4−/− mice compared 
with control mice, and total white blood cell count was 
also not affected by PMCA4 deletion (Fig. 1C–H).
There is evidence that the maturation programme 
of red blood cells, specifically immature reticulocytes, 
is influenced by intracellular calcium concentrations 
[21]. Therefore, image stream analysis was performed to 
investigate if PMCA4 deletion influenced the maturation 
state of red blood cells (Fig.  2A, B). Surprisingly, there 
was no difference in the frequencies of reticulocytes 
 (CD71+) within the RBC  (Ter119+) population between 
 PMCA4−/− and WT mice (Fig.  2C). It is also impor-
tant to note that there were only very few early eryth-
roblasts  (CD44+ cells) observed in the analyses (results 
not shown). The image stream analysis did show that the 
mean circularity ratio of mature  Ter119+ normocytes and 
 CD71+ reticulocytes was slightly lower in  PMCA4−/− 
mice, suggesting that PMCA4 deficiency affected RBC 
morphology (Fig.  2D). In contrast to the results from 
the automatic blood analyser, the image stream analysis 
did not reveal any major differences in the size of mature 
normocytes or immature reticulocytes in the  PMCA4−/− 
mice, compared with control WT mice (Fig. 2E).
Combined, these data indicate that the deletion of 
PMCA4 had an effect in modulating the haemoglobin 
content of RBCs (an important determinant that can 
influence Plasmodium growth and survival within RBCs), 
and potentially had a small impact on RBC size.
Deletion of PMCA4 does not affect the course 
of blood‑stage Plasmodium chabaudi infection
To investigate how systemic abrogation of PMCA4 
expression, and the associated alterations in RBC prop-
erties, affected the course of blood-stage malaria, the 
 PMCA4−/− and WT littermate mice were infected with P. 
chabaudi parasites, a species of rodent Plasmodium that 
predominantly infects mature erythrocytes (normocytes) 
(See figure on next page.)
Fig. 1 The effect of PMCA4 deletion on RBC properties. Blood was obtained from uninfected  PMCA4−/− and wild type (WT) littermates. A Western 
blot analysis examining A PMCA4 and B PMCA1 expression in whole blood cell lysates. C–H Whole blood examination by automated blood 
analyser investigating C total RBC count, D white blood cell counts, E haemoglobin level, F haematocrit, G mean corpuscular volume and H mean 
corpuscular haemoglobin level (n = 5 in each group, *P < 0.05, **P < 0.01)














Fig. 1 (See legend on previous page.)
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and which causes recrudescing and chronic malarial 
disease [22, 23]. Unexpectedly, there were no qualita-
tive differences in the morphology (diameter or shape) 
of infected RBCs in  PMCA4−/− and WT mice (as shown 
on day 7 and 9 infection) (Fig. 3A). Moreover, there were 













WT            PMCA4-/-
* * 
Fig. 2 Image stream analysis to assess RBC maturation. Blood was obtained from uninfected  PMCA4−/− and wild type (WT) littermates. A 
Representative image stream pictures showing RBC morphology and Ter119 (pan RBC), CD71 (reticulocyte) and CD44 (early erythroblast) expression 
and B representative dot plot showing CD71 expression by  Ter119+ RBCs. C Percentage of  Ter119+ RBCs that are  CD71+ reticulocytes. D Mean 
circularity ratio and E average area of  Ter119+ mature RBCs and  Ter119+CD71+ reticulocytes (N = 3 in each group, *P < 0.05)
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phenotype, of early ring stage, trophozoite or schizont 
intraerythrocytic stages of the parasite, or abundance of 
extracellular parasites, in  PMCA4−/− and WT littermate 
mice (Fig.  3A). In agreement, the course of P. chabaudi 
infection was comparable in  PMCA4−/− and littermate 
WT mice, with no difference in level of peak parasitae-
mia on day 9 of infection and equivalent size of recrudes-
cence, which was cleared at equal rate, in  PMCA4−/− and 
WT mice (Fig. 3B). Correspondingly, there were no dif-
ferences in signs of disease morbidity (reduction in RBCs 
per ml or weight) between  PMCA4−/− and WT mice 
during the course of P. chabaudi infection (Fig.  3C, D). 
Moreover, computational image analysis of Giemsa-
stained thin blood smears suggested that there were no 
marked differences in the radius ratio, circumference 
(perimeter), diameter and circularity of RBCs during 
the course of P. chabaudi infection between  PMCA4−/− 
and WT mice (Additional file  1: Fig.  S1A–D). Analysis 
of reticulocyte level also showed no difference between 
 PMCA4−/− and WT mice during P. chabaudi infection 
(Additional file  1: Fig.  S1E). Thus, surprisingly, genetic 
deletion of PMCA4 did not significantly influence the 
disease severity or level of peripheral parasitaemia during 
P. chabaudi AS infection.
Deletion of PMCA4 does not affect the course 
of reticulocyte‑restricted Plasmodium yoelii infection
Abrogation of PMCA4 did not affect the course of 
P. chabaudi infection, in which the parasite primar-
ily invades mature erythrocytes. Plasmodium parasites 
have differing requirements for growth and survival in 
reticulocytes than in mature erythrocytes [24] and cal-
cium levels are differentially controlled in reticulocytes 
than in normocytes [21, 25]. Therefore, it is important to 
investigate if the absence of PMCA4 affected the course 
of infection caused by a reticulocyte-restricted para-
site, P. yoelii, which typically causes a gradual and self-
resolving blood-stage malaria [26]. As expected, P. yoelii 
parasites exhibited a strong preference for reticulocytes 
(Fig.  4A). There were no qualitative differences in the 
extent of restriction of parasites towards reticulocytes in 
 PMCA4−/− and WT mice, as shown on days 7 and 11 of 
infection (Fig. 4A). The morphology of infected reticulo-
cytes were also unaltered in  PMCA4−/− and WT mice, 
and the relative proportions and phenotype of the differ-
ent intra-erythrocytic life-cycle stages were qualitatively 
comparable in  PMCA4−/− mice compared with WT 
mice (Fig.  4A). Accordingly, there were no significant 
differences in the course of P. yoelii infection (as deter-
mined by peripheral parasite levels, RBC/ml counts and 
percentage weight change), in  PMCA4−/− mice com-
pared with WT mice (Fig.  4B–D). Similar to the find-
ing in P. chabaudi AS model, there were no significant 
changes in the radius ratio, circumference (perimeter), 
diameter and circularity of RBCs during the course of P. 
yoelii infection between  PMCA4−/− and WT mice (Addi-
tional file 1: Fig. S2A–D). Reticulocyte level, as indicated 
by analysis on Giemsa-stained blood smear, was not dif-
ferent between  PMCA4−/− and WT mice during P. yoelii 
infection (Additional file 1: Fig. S2E). Thus, knock out of 
PMCA4 did not affect the dynamics or severity of reticu-
locyte-restricted blood-stage malaria in mice.
Deletion of PMCA4 provides partial protection 
against experimental cerebral malaria
The PMCA4 gene is an identified resistance locus for cer-
ebral malaria, the development of which is often poorly 
correlated with circulating parasite levels [27]. Thus, 
whilst the above results suggested that PMCA4 did not 
significantly influence peripheral parasitaemia and the 
course of mild murine blood-stage malarias, this did not 
rule out a role for PMCA4 in influencing severe malar-
ial disease. To address this, the development of ECM in 
 PMCA4−/− mice during blood-stage P. berghei infection 
was assessed. As expected,  PMCA4−/− mice and WT lit-
termate mice exhibited equivalent peripheral parasite 
burdens during P. berghei infection (Fig.  5A). However, 
 PMCA4−/− mice were partially resistance to develop-
ment of ECM, with 20% of PMCA4 KO mice (compared 
with 0% of WT littermate mice) surviving the window 
period of ECM development (day 6–10) (Fig.  5B). In 
agreement, on day 6 of infection, when WT mice began 
showing signs of ECM,  PMCA4−/− mice showed quali-
tatively variable, but generally lower, levels of Evans blue 
staining within the brain compared with WT littermate 
mice (Fig. 5C). This qualitative assessment indicates that 
the absence of PMCA4 variably reduced and /or delayed 
blood brain barrier disruption during P.berghei infection, 
consistent with the staggered kinetics of ECM and the 
resistance of a small proportion of  PMCA4−/− mice to 
the syndrome.
ECM is a T cell-dependent syndrome, where T cells 
undergo activation in the spleen before migrating to 
the brain where they interact with endothelial cells lin-
ing the cerebrovasculature, causing blood brain bar-
rier damage through Granzyme B production [28–31]. 
(See figure on next page.)
Fig. 3 The course of P. chabaudi AS infection in  PMCA4−/− mice.  PMCA4−/− and WT littermate mice were infected (i.v.) with  104 P. chabaudi AS 
pRBCs. A Representative pictures of Giemsa‑stained thin blood smears showing RBCs and pRBCs from days 7 and 9 of infection. B–D The course 
of infection as measured by B peripheral parasitaemia. C RBC counts and D change in body weight. The results are from one of three independent 
experiments with n = 3–5 per group, in each independent experiment
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Fig. 3 (See legend on previous page.)
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Thus, it is important to examine if the partial resistance 
of  PMCA4−/− mice to ECM was associated with altera-
tions in the splenic and/or intracerebral T cell response. 
Abrogation of PMCA4 did not significantly alter the 
numbers of activated (antigen-experienced)  CD4+ and 
 CD8+ T cells (as defined by upregulation and co-expres-
sion of CD11a and CD49d [32, 33];) in the spleen on day 
7 of infection. Nor did deletion of PMCA4 affect the per-
centages of antigen-experienced splenic  CD4+ T cells or 
 CD8+ T cells expressing Granzyme B (Fig. 6A-F). How-
ever, the numbers of antigen-experienced T cells accu-
mulating in the brain trended lower in  PMCA4−/− mice 
on day 7 of infection (compared with WT littermate 
mice) and intracerebral antigen-experienced  CD4+ and 
 CD8+ T cells expressed slightly (but significantly) lower 
levels of GrB in infected  PMCA4−/− mice than in WT lit-
termate mice (Fig.  7A–F, with gating strategy as shown 
in Additional file 1: Fig. S1). Of note, there were no dif-
ferences in microglial numbers or neutrophil or mono-
cyte accumulation within the brains of  PMCA4−/− and 
WT mice on day 7 of infection (Fig. 7G, including Addi-
tional file  1: Fig.  S1). Moreover, ICAM-1 expression by 
brain  CD31+ cells (putative endothelial cells), was also 
comparable in infected  PMCA4−/− and WT mice on day 
7 of infection (Fig. 7H–I). Thus, the partial resistance of 
 PMCA4−/− mice to ECM was associated with a slight 
reduction in the strength of pathogenic intracerebral T 
cell response, rather than a generalized dampening of 
cerebral inflammation.
Discussion
The key finding of our study is that genetic ablation of 
PMCA4 expression in mice slightly improved the survival 
against P. berghei infection, which is a common murine 
model of cerebral malaria. However, PMCA4 deficiency 
did not alter the course of non-lethal malaria during P. 
chabaudi and P. yoelii infections. Moreover, the deletion 
of PMCA4 did not impact peripheral parasite levels dur-
ing any of the murine malaria models examined.
The PMCA4 SNPs that have been associated with risk 
to severe malarial disease are believed to control the 
level of PMCA4 expressed on RBCs [34]. Specifically, 
PMCA4 SNPs that correspond with reduced PMCA4 
expression (and consequent increased intracellular  Ca2+ 
levels) appear to be associated with protection against 
severe malaria [34]. PMCA4-deficiency in red blood cells 
has previously been shown to lead to increased mean 
corpuscular haemoglobin concentration (indicating 
reduced RBC hydration), likely due to Ca-induced acti-
vation of potassium channel resulting in potassium efflux 
and volume loss (the Gardos effect) [13]. The hydration 
state of RBCs has been demonstrated to strongly influ-
ence the invasion and growth of Plasmodium parasites, 
with P. falciparum parasites being unable to invade dehy-
drated cells, potentially due to membrane-cytoskeletal 
alterations precluding correct orientation of merozoites 
[14, 35]. Thus, it was very surprising that there did not 
appear to be any obvious differences in the status of 
intra-erythrocytic parasites, or the morphology of para-
sitized RBCs, in  PMCA4−/− mice compared with WT 
mice, and that peripheral parasitaemia levels were not 
altered in  PMCA4−/− mice during any of the investigated 
murine Plasmodium spp. infections within this study.
Whilst the above analyses did show differences in the 
mean corpuscular haemoglobin levels in RBCs from 
 PMCA4−/− mice, the majority of other analysed RBC 
properties (size, morphology, maturation) were only 
minorly affected or were unaffected by abrogation of 
PMCA4 expression. Indeed, whilst the results from the 
automated blood analyser suggested that mean corpus-
cular volume of RBCs was lower in  PMCA4−/− mice, this 
was not recapitulated within the image stream analysis. 
There were also no obvious signs of increased propor-
tions of crenated and dehydrated RBCs, or difference 
in RBC diameter, perimeter and circulaty in infected 
 PMCA4−/− mice when studying Giemsa-stained thin 
blood smears. Thus, the data suggests that abrogation 
of PMCA4 in murine RBCs may not perturb RBC prop-
erties to a sufficient level to affect Plasmodium parasite 
invasion, growth or survival. Indeed, the effect of RBC 
dehydration on parasite invasion and growth appears to 
be a graded phenomenon that only becomes significant 
above a threshold level of dehydration [14]. The finding 
of this study, therefore, appears to question the dominant 
impact of PMCA4 in controlling Plasmodium invasion, 
growth or survival within RBCs (normocytes or reticulo-
cytes) during murine malaria.
It is important to note that it has yet to be definitively 
shown in any study that PMCA4 directly affects Plasmo-
dium parasite growth in RBCs. To directly test this ques-
tion it will be necessary to isolate RBCs from individuals 
with different PMCA4 SNPs and culture them in  vitro 
with P. falciparum parasites. As intracellular  Ca2+ levels 
dictate many different biophysical properties of RBCs 
[36], the possibility that alterations in PMCA4 expression 
Fig. 4 The course of P. yoelii NL infection in  PMCA4−/− mice.  PMCA4−/− and WT littermate mice were infected (i.v.) with  104 P. yoelii NL pRBCs. A 
Representative pictures of Giemsa‑stained thin blood smears showing RBCs and pRBCs from days 7 and 11 of infection. The course of infection as 
measured by B peripheral parasitaemia, C RBC counts and (D) change in body weight. The results are from one of three independent experiments 
with n = 3–5 per group, in each independent experiment
(See figure on next page.)
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level affect other pRBC properties cannot be discounted. 
This includes several pRBCs properties, such as trans-
port and membrane expression of Plasmodium proteins 
and cellular deformability, that could influence the devel-
opment of severe malaria, and which may feature more 
prominently in human blood-stage malaria than murine 
malaria. Moreover, in extreme cases, alterations in the 
morphology of RBCs may lead to increased phagocytosis 
within the spleen by red pulp macrophages, which clear 
damaged and old RBCs from circulation.
Several studies have shown that some genetic condi-
tions involving haemolytic anaemia (including thalas-
semia and sickle cell disease) are often associated with 
“leakiness” of the RBC membrane, which lead to the 
increase in intracellular  Ca2+ level [36]. However, other 
reported observations have shown that the mechanisms 
underlying protection against malaria in these condi-
tions were reduction in haemoglobin level [37] and 
reduction in parasite cytoadherence [38], but not due to 
the increase in RBCs’  Ca2+ level. This is in line with the 
finding in  PMCA4−/− mice that the levels of parasitaemia 
following P. chabaudi and P. yoelii infection were not dif-
ferent between WT and  PMCA4−/− mice.
Although the focus of the present study was on the 
potential role of PMCA4 on RBCs in influencing the 
course of blood stage malaria, the PMCA isoforms 1 
and 4 are ubiquitously expressed in most organs and 
cell types [9]. Interestingly, PMCAs may have different 
roles and functions in different cell types. For exam-
ple, in vascular smooth muscle cells and in cardiac 
myocytes PMCA4 appears to modulate cellular signal-
ling, including regulating nitric oxide (NO) production 
by neuronal nitric oxide synthase (nNOS)[39–41]. In 
endothelial cells, PMCA4 modulates vascular endothe-
lial growth factor (VEGF)-induced angiogenesis via 
regulation of calcineurin [42]. In fibroblast cell line 
L929, PMCA4 is involved in regulating signalling path-
ways controlling responsiveness to tumour necrosis 
factor (TNF)[43], whilst in T-cells, PMCA4 is involved 
in the production of inflammatory cytokines, such as 
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Fig. 5 The development of ECM in  PMCA4−/− mice during P. berghei ANKA infection. PMCA‑4−/− and WT littermate mice were infected (i.v.) 
with  104 P. berghei ANKA pRBCs. A, B The course of infection as measured by (A) peripheral parasitaemia and B survival. C Representative pictures 
showing level of Evans blue penetration into brain on day 6 of infection (Evans blue injected (i.v.) 1 h prior to removal of brain). A The results are 
from one of three independent experiments with n = 3–5 per group, per experiment. B The data includes all mice used in the project (n = 34 per 
group, * P < 0.05)
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Fig. 6 The effect of PMCA4 ablation on splenic immune responses during P. berghei ANKA infection.  PMCA4−/− and WT littermate mice were 
infected (i.v.) with  104 P. berghei ANKA pRBCs. A, B The numbers of antigen‑experienced (Ag‑exp:  CD11a+CD49d+) A  CD4+ T cells and B  CD8+ T cells 
in the spleen on day 6 of infection. C, D Representative histograms and percentages of splenic E Ag‑exp  CD4+ T cells and F Ag‑exp  CD8+ T cells 
expressing Granzyme B on day 6 of infection. (Data are from one of two independent experiments with n = 4–5 per group, per experiment)
(See figure on next page.)
Fig. 7 Analysis of cerebral T‑cells during P. berghei infection.  PMCA4−/− and WT littermate mice were infected (i.v.) with  104 P. berghei pRBCs. A, B The 
numbers of A Ag‑exp  CD4+ T cells and B Ag‑exp  CD8+ T cells in the brain on day 6 of infection. C, D Representative histograms and percentages of 
intracerebral E Ag‑exp  CD4+ T cells and F Ag‑exp  CD8+ T cells expressing Granzyme B on day 6 of infection. G The numbers of inflammatory  (Ly6c+) 
monocytes in the brain on day 6 of infection. H and I Representative histograms and percentages of  CD31+CD45− endothelial cells expressing 
ICAM‑1 on day 6 of infection. The results are from one of two independent experiments with n = 4–5 per group, per experiment (* p < 0.05)
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Fig. 7 (See legend on previous page.)
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interleukin-2 (IL-2) [44]. Endothelial cells and various 
leucocyte populations including macrophages, neutro-
phils and T cells, play important roles in the pathogen-
esis of severe malarial disease syndromes, including 
cerebral malaria. Consequently, it is foreseeable that 
the association of PMCA4 SNPs with risk of severe 
malaria is not solely RBC-dependent, but is multifac-
torial, involving modulation of host pro-inflammatory 
immune responses and control of vascular homeosta-
sis. In support of this, we observed qualitatively lower 
damage to the blood brain barrier in  PMCA4−/− mice 
compared with control mice during P. berghei infec-
tion, corresponding with the slightly increased resist-
ance of  PMCA4−/− mice to ECM. In addition, there 
was a trend towards lower numbers of T cells in the 
brains of  PMCA4−/− mice during Plasmodium berghei 
infection, and intracerebral T cells that did accumulate 
also expressed lower levels of Granzyme B in infected 
 PMCA4−/− mice. Although the IFN-g production by 
brain accumulating  CD8+ T cells was not assessed, it 
can be anticipated that the level of this cytokine may 
also have been lower within infected  PMCA4−/− mice 
than in infected control WT mice, given that Gran-
zyme B and IFN-g are sensitive measures of  CD8+ T 
cell pathogenic activity during P. berghei infection [30]. 
Notably, however, the numbers of monocytes, neutro-
phils and resident microglial cells within the brain were 
not significantly altered in  PMCA4−/− mice compared 
with control WT mice during P. berghei infection. This 
suggests that global PMCA4 deletion did not lead to a 
generalized amelioration of neuroinflammation during 
P. berghei infection. Thus, further work will be required 
to assess whether the specific alterations in T cell activ-
ity in the brain of infected  PMCA4−/− mice, and the 
associated slight increase in resistance to ECM, was 
due to cell autonomous effects of PMCA4 deficiency or 
was caused by other discrete indirect effects within the 
brain. Indirect effects that may influence  CD8+ T cell 
responses in the brain during P. berghei ANKA infec-
tion could potentially include reduced pRBC accumula-
tion and cross presentation of parasite antigen by brain 
endothelial cells, or alterations in CXCL9 and CXCL10 
production, which are critical events in the pathogen-
esis of ECM [45–48].
Conclusions
Studies using  PMCA4−/− mice indicate that although 
PMCA4 ablation in RBC does not seem to affect Plasmo-
dium life cycle in RBCs, PMCA4 may be involved, at least 
in part, in the development of cerebral malaria.
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